PATRICIA PAULHUS: Open Payments
NPI 1326310640 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 48 payments from 13 companies in 2025. Trend: 2023 $1,192 · 2024 $958 · 2025 $1,096
Food & beverage: $1,082Education: $13
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 7 | $299 |
| Vifor Pharma, Inc. | 9 | $215 |
| AKEBIA THERAPEUTICS INC | 8 | $206 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Fresenius USA Marketing, Inc. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: IBSRELA, Veltassa, Vafseo, JARDIANCE, VELPHORO, LOKELMA, Fabhalta, FARXIGA.
Industry payments across CA — which companies pay providers there.
